Paola Domizio Undergraduate Essay Prize is now open! Entries are welcomed until 23.59 GMT on Monday 25 April 2022.
Paola Domizio Undergraduate Essay Prize 2022
This year's Paola Domizio Undergraduate Essay Prize is now open! Entries are welcomed until 23.59 GMT on Monday 25 April 2022.
If you are passionate about pathology or are an aspiring pathologist studying any related undergraduate course, the Paola Domizio Undergraduate Essay Prize is your opportunity to demonstrate your enthusiasm and explore a fascinating subject through writing.
From 2019 for a period of five years the competition will be posthumously named after Professor Paola Domizio, an RCPath Fellow who contributed a huge amount to the work of the College, and to pathology education.
QUESTION FOR 2022
The essay question for this year’s prize was 'Which one scientific discovery or pathologist has had the most significant impact on medicine/pathology in the last 60 years?'.
FURTHER INFORMATION ABOUT THE COMPETITION
This competition runs annually and is open to medical, biological science and veterinary science undergraduates.
The Paola Domizio Undergraduate Essay Prize 2022 will open on Monday 28 February and close at 23.59 GMT on Monday 25 April 2022.
The essay has to be no more than 1,000 words, excluding references and bibliography.
A prize of £250 will be awarded to the winning entrant, as well as having their essay published on our website and in the College magazine, The Bulletin.
Full details, including essay specifications and format, are in the Terms and Conditions document, which can be found below.
HOW TO ENTER
Submit your essay in either Microsoft Word (doc, docx) format or PDF format and email it to publicengagement@rcpath.org and include the subject line 'Undergraduate Essay Prize 2022'.
Please download the front cover below and use it to submit your essay; keep all other pages of your essay anonymous (free of any personal information).
The front page will be removed before essays go to the judging panel. Please note that we are only accepting online submissions. Further information is in the Terms and Conditions document below.
COMMENTS